BridgeBio Pharma, Inc. remains a Buy, driven by Attruby’s strong U.S. launch and favorable competitive dynamics. Learn more ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

BridgeBio Pharma Inc. (NASDAQ:BBIO) is one of the stocks with explosive growth potential. On February 24, BridgeBio Pharma reported a transformative full-year 2025, marked by a surge in total revenue ...

Peptide injections have become the wellness world’s biggest health hack. Proponents believe these shots can build muscle, rejuvenate skin, heal injuries, and otherwise promote vitality and longevity.

A new gene therapy is giving people born deaf the chance to hear, often within just weeks. In a small but groundbreaking study, researchers delivered a working copy of a key hearing gene directly into ...

Los Angeles Lakers star Luka Doncic seeks to do whatever necessary to speed up his injury rehab. Doncic, 27, has reportedly jetted off to Spain in hopes of pursuing specialized treatment for a Grade 2 ...

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She’s passionate about helping individuals live full, healthy and happy lives at ...

In other recent news, BridgeBio Pharma has been in the spotlight with several significant developments. Barclays has reiterated an Overweight rating on the company, projecting first-quarter U.S.

Stocks extended their rally Thursday, even as oil prices gained, amid continued optimism among traders that the fragile two-week ceasefire between the U.S. and Iran could be sustained. The S&P 500 ...

Injectable peptides are the new anti-ageing trend sweeping the beauty industry. These compounds are promoted on social media as tools for skin repair, collagen production and “cellular rejuvenation”.